MS-553, a Selective PKC-ß Inhibitor Inhibits BCR Signaling and Synergizes with Venetoclax for the Treatment of High Risk CLLJyotsana Singh,Daisy Diaz Rohena,Chaomei Liu, Bailey Slawin,Janani Ravikrishnan,Nitin Jain,William G. Wierda,Kai Zhang, Michael Niesman,Jennifer A. Woyach,Deepa SampathBlood(2022)引用 1|浏览8暂无评分关键词venetoclax,high risk cll,bcrAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要